Desert Labs’ Hoodia parviflora product demonstrated significantly better results for loss in weight, waist circumference and Body Mass Index (BMI) as compared to the control group.

New York, NY and Yotvata, Israel - Desert Labs Ltd. announces the publication of the study results in an article titled: “Efficacy and Acceptance of a Commercial Hoodia parviflora Product for Support of Appetite and Weight Control in a Consumer Trial” in the Journal Of Medicinal Food published by Mary Ann Liebert, Inc. The study demonstrated that for normal weight, overweight and obese individuals ingesting its Hoodia parviflora, there were significantly better results for loss in weight, waist circumference and Body Mass Index (BMI) as compared to the control group. Very obese individuals, with a BMI of greater than 35, did not show a significant improvement.

The company carried out the 40 day, single-blind, randomized and placebo-controlled trial in New York City.  

103 volunteers completed the study to determine the efficacy of and tolerance for its Hoodia parviflora product. The process and results of the trial appear currently as a peer reviewed article and can be found on ‘PubMed’.  

Highlights of the study results are in the following charts: